Assembling the Care Team and Long-Term Surveillance
At a Glance
Children with neonatal ichthyosis-sclerosing cholangitis syndrome need coordinated care from liver, skin, genetics, and nutrition specialists. Because liver involvement can change, monitoring is individualized, with urgent action for jaundice, bleeding, fever, confusion, or rapid abdominal swelling.
Because Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome (NISCS) affects multiple systems—the skin, liver, hair, and teeth—managing it requires a coordinated group of specialists. This “multidisciplinary team” works together to monitor your child’s progress and catch potential complications early [1][2].
Building Your Care Team
Your child’s team will likely be centered around several key specialists:
- Pediatric Hepatologist: A liver specialist who will lead the long-term monitoring of the bile ducts and liver function [1].
- Pediatric Dermatologist: A skin specialist to manage the ichthyosis and monitor for skin infections or hair loss [1][3].
- Medical Geneticist: To provide counseling and help you understand the CLDN1 mutation and what it means for your family [1][3].
- Specialist Dietitian: To ensure your child is getting enough calories and safely absorbing fat-soluble vitamins (A, D, E, and K) to support growth [4][5].
Long-Term Surveillance
Because liver involvement in NISCS can be unpredictable, your child will need regular check-ups to monitor the health of their liver and bile ducts. There is no universally established monitoring schedule for this rare condition, so surveillance must be individualized [1].
Monitoring the Liver and Bile Ducts
Doctors use several tools to track your child’s health over time:
- Blood Work: Regular tests for liver enzymes (like GGT, AST, and ALT, which measure inflammation), bilirubin, and protein levels (albumin). Importantly, they will also measure synthetic liver function—like PT/INR, which shows how well the liver is making clotting factors. They will also monitor platelet counts, as a drop in platelets can be an early sign of liver scarring or portal hypertension [6][7].
- MRCP (Magnetic Resonance Cholangiopancreatography): This is an MRI scan used to create detailed images of the anatomy of the bile ducts. It helps doctors see if there is any new narrowing (strictures) or dilation, though it does not reliably measure liver scarring (fibrosis) and may require sedation in young children [8][9].
- Ultrasound with Doppler: This helps measure the size of the liver and spleen and checks the direction of blood flow in the liver’s veins [10][11].
Screening for Portal Hypertension
If the liver develops significant scarring, it can lead to portal hypertension (high pressure in the veins of the liver). Your team will look for signs of this through:
- Physical Exams: Checking for an enlarged spleen (splenomegaly) or fluid in the abdomen (ascites) [12][13].
- Endoscopy: If imaging, blood tests, age, and bleeding risk suggest the need, a specialist may perform an endoscopy (using a small camera) to look for varices—enlarged veins in the esophagus that could potentially bleed [14][15].
Knowing When to Seek Urgent Help
It is vital to have a written, age-specific emergency plan from your child’s hepatologist.
Expected (Stable) Symptoms
These are typically not emergencies but should be discussed at your next scheduled appointment:
- Typical dry, scaly skin or hair loss.
- Chronic itching that is being actively managed by your current medications.
Same-Day / Urgent Medical Contact
In an infant or young child, jaundice and stool color changes are never something to watch and wait on. Contact your hepatologist or pediatrician immediately or seek same-day assessment if you notice:
- Worsening Jaundice: Persistent, new, or sudden increase in the yellowing of the skin or eyes [16].
- Pale or clay-colored stools, or unusually dark urine.
- Poor feeding, decreased wet diapers, or repeated vomiting.
- Increased Itching: Pruritus that suddenly becomes much more intense or prevents sleep [17].
- Signs of Skin Infection: Increasing redness, warmth, or oozing from dry skin areas [18].
Emergency “Red Flags” (Call 911 or go to the ER)
Seek emergency medical care immediately for the following:
- Signs of Cholangitis or Sepsis: Fever or temperature instability (e.g., 38°C/100.4°F or higher in an infant), chills, or sudden unusual lethargy. Cholangitis is an infection of the bile ducts, and sepsis is a life-threatening systemic infection [19][20].
- Gastrointestinal Bleeding: Vomiting blood (which may look like coffee grounds) or passing black, tarry, or bloody stools. This can indicate a bleeding varix [21][12].
- Hepatic Encephalopathy: A sudden, unusual change in alertness, behavior, or severe confusion [12][22].
- Rapid Abdominal Swelling: A sudden, tight distension of the belly that causes discomfort or difficulty breathing [21][13].
Common questions in this guide
Which specialists should care for a child with NISCS?
What tests monitor NISCS over time?
How often should a child with NISCS have liver surveillance?
When might a child with NISCS need an endoscopy?
What warning signs mean that a child with NISCS needs urgent care?
One line in your results can change your plan.
Imaging and blood test results, along with age and bleeding risk, may suggest whether an endoscopy is needed. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Neonatal ichthyosis-sclerosing cholangitis syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (22)
- 1
Neonatal ichthyosis-sclerosing cholangitis syndrome caused by a novel CLDN1 mutation: a case report and literature review.
Ghosh U, Agrawal A, Srinivasan VM, et al.
Clinical and experimental pediatrics 2025; (68(11)):858-867 doi:10.3345/cep.2025.00906.
PMID: 41035246 - 2
Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP.
Díaz-González Á, Molera C, Gómez-Domínguez E, et al.
Gastroenterologia y hepatologia 2026; (49(4)):502629 doi:10.1016/j.gastrohep.2025.502629.
PMID: 41232665 - 3
CLDN1 Arg81His founder variant causes ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis (ILVASC) syndrome in Moroccan Jews.
Eskin-Schwartz M, Dolgin V, Didkovsky E, et al.
Clinical genetics 2024; (105(1)):44-51 doi:10.1111/cge.14432.
PMID: 37814412 - 4
Nutrition support of children with chronic liver disease: A rapid review and consensus statements from Australasian society of parenteral and enteral nutrition (AuSPEN) Paediatric liver group.
Burgess D, Collins T, Landorf E, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2026; (58(7)):862-870 doi:10.1016/j.dld.2026.05.006.
PMID: 42225462 - 5
Malnutrition in Pediatric Chronic Cholestatic Disease: An Up-to-Date Overview.
Tessitore M, Sorrentino E, Schiano Di Cola G, et al.
Nutrients 2021; (13(8)) doi:10.3390/nu13082785.
PMID: 34444944 - 6
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.
Deneau MR, Mack C, Perito ER, et al.
Hepatology (Baltimore, Md.) 2021; (73(3)):1074-1087 doi:10.1002/hep.31393.
PMID: 32464706 - 7
Primary sclerosing cholangitis in children: a single-center experience and evaluation of prognostic markers.
Vlckova E, Hradsky O, Semjonov V, et al.
Translational gastroenterology and hepatology 2026; (11()):18 doi:10.21037/tgh-25-57.
PMID: 41675340 - 8
Assessment of disease severity with magnetic resonance cholangiography in pediatric-onset primary sclerosing cholangitis.
Vanhanen E, Ovissi A, Kolho KL, Tenca A
Journal of pediatric gastroenterology and nutrition 2024; (79(3)):644-651 doi:10.1002/jpn3.12319.
PMID: 39014988 - 9
Longitudinal changes in quantitative magnetic resonance imaging metrics in children and young adults with autoimmune liver disease.
Mahalingam N, Trout AT, Zhang B, et al.
Abdominal radiology (New York) 2023; (48(6)):1933-1944 doi:10.1007/s00261-022-03733-9.
PMID: 36799997 - 10
Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients.
Foroutan HR, Bahador A, Ghanim SM, et al.
Pediatric surgery international 2020; (36(5)):603-610 doi:10.1007/s00383-020-04641-z.
PMID: 32206891 - 11
Long-term outcome following cholecystocolostomy in 41 patients with progressive familial intrahepatic cholestasis.
Li Q, Chong C, Sun R, et al.
Pediatric surgery international 2021; (37(6)):723-730 doi:10.1007/s00383-021-04871-9.
PMID: 33651176 - 12
Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE, Dzyubak B, Venkatesh SK, et al.
Journal of gastroenterology and hepatology 2016; (31(6)):1184-90 doi:10.1111/jgh.13263.
PMID: 26691631 - 13
Primary Sclerosing Cholangitis-Autoimmune Hepatitis Overlap Syndrome: Significant Barriers in Liver Disease Diagnosis and Treatment Experienced by the Latino Community.
Guifarro DA, De Oliveira-Gomes D, Beas R, et al.
Cureus 2023; (15(3)):e36126 doi:10.7759/cureus.36126.
PMID: 37065404 - 14
Role of Endoscopy in Primary Sclerosing Cholangitis.
Bhat P, Aabakken L
Clinical endoscopy 2021; (54(2)):193-201 doi:10.5946/ce.2020.019-IDEN.
PMID: 32380796 - 15
Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Moctezuma-Velazquez C, Saffioti F, Tasayco-Huaman S, et al.
The American journal of gastroenterology 2019; (114(3)):446-452 doi:10.1038/s41395-018-0265-7.
PMID: 30315285 - 16
Current Therapeutics in Primary Sclerosing Cholangitis.
Tan N, Lubel J, Kemp W, et al.
Journal of clinical and translational hepatology 2023; (11(5)):1267-1281 doi:10.14218/JCTH.2022.00068S.
PMID: 37577219 - 17
Development of a Novel Tool to Assess the Impact of Itching in Pediatric Cholestasis.
Kamath BM, Abetz-Webb L, Kennedy C, et al.
The patient 2018; (11(1)):69-82 doi:10.1007/s40271-017-0266-4.
PMID: 28710680 - 18
Infant skin care: updates and recommendations.
Johnson E, Hunt R
Current opinion in pediatrics 2019; (31(4)):476-481 doi:10.1097/MOP.0000000000000791.
PMID: 31188166 - 19
Primary sclerosing cholangitis.
Dyson JK, Beuers U, Jones DEJ, et al.
Lancet (London, England) 2018; (391(10139)):2547-2559 doi:10.1016/S0140-6736(18)30300-3.
PMID: 29452711 - 20
[Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2020; (75(5)):246-256 doi:10.4166/kjg.2020.75.5.246.
PMID: 32448856 - 21
Acute-on-chronic hepatitis. A case report of autoimmune hepatitis/primary sclerosing cholangitis/ulcerative colitis overlap syndrome in a 15-year-old patient.
Nalepa A, Woźniak M, Cielecka-Kuszyk J, et al.
Clinical and experimental hepatology 2017; (3(1)):28-32 doi:10.5114/ceh.2017.65501.
PMID: 28856287 - 22
Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?
Sandrasegaran K, Shah AS, Thompson CP, et al.
European radiology 2026; doi:10.1007/s00330-026-12710-5.
PMID: 42363965
This page explains care coordination and long-term surveillance for children with NISCS for informational purposes only and does not replace medical advice. Follow your child's individualized plan and seek urgent care for warning signs.